ArticleFrontiers in oncology2019

Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma.

Maurice Michel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.